SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-095396
Filing Date
2023-08-25
Accepted
2023-08-25 17:08:39
Documents
4
Period of Report
2023-09-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2323671-2_def14a.htm DEF 14A 494396
2 GRAPHIC lg_petros-4clr.jpg GRAPHIC 33620
3 GRAPHIC px_petros1pg1-bw.jpg GRAPHIC 765418
4 GRAPHIC px_petros1pg2-bw.jpg GRAPHIC 659620
  Complete submission text file 0001104659-23-095396.txt   2259858
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39752 | Film No.: 231209209
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences